Almost 35% of drugs approved by the Food and Drug Administration work by targeting G protein-coupled receptors (GPCRs), ...

Researchers at the University of Chicago have successfully captured detailed images of adhesion G protein-coupled receptors, ...

In a significant advancement for cancer research, a team of scientists from Max Planck Institute for Biology Tübingen, ...

GMA-106 is under development for the treatment of type 2 diabetes, obesity and non-alcoholic steatohepatitis (NASH). The drug candidate is being developed based on Bibody platform. It acts by ...

Tectonic Therapeutic, Inc. has seen a significant stock rally which has seen its shares nearly triple since this summer. What ...

Recent advancements in understanding the molecular basis of the prostaglandin D2 receptor (DP2) have significant implications ...

Breast cancer remains a leading health crisis worldwide, claiming the lives of approximately 685,000 women in 2020 alone.

Researchers at the University of Chicago have captured complete images of adhesion G protein-coupled receptors and an ...

After years of restructuring, Chicago-based Exicure has South Korean majority ownership and is buying the U.S. arm of a South ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...